Deepak Dalvie

机构：Bristol-Myers Squibb (Germany) · ORCID：0000-0001-6196-5314

发表论文 133 篇 · 总被引 6050 次 · h-index 41

代表论文

Aldehyde oxidase and its role as a drug metabolizing enzyme (2019 · Pharmacology & Therapeutics · 被引 88)
Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor Modulator (2021 · Drug Metabolism and Disposition · 被引 76)
Future of Biotransformation Science in the Pharmaceutical Industry (2021 · Drug Metabolism and Disposition · 被引 16)
Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5 (2021 · Journal of Pharmacology and Experimental Therapeutics · 被引 10)
Investigation into MAO B–Mediated Formation of CC112273, a Major Circulating Metabolite of Ozanimod, in Humans and Preclinical Species: Stereospecific Oxidative Deamination of (S)-Enantiomer of Indaneamine (RP101075) by MAO B (2021 · Drug Metabolism and Disposition · 被引 9)
Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants (2025 · British Journal of Clinical Pharmacology · 被引 7)